How does neuropathic pain - the one that no drug can kill as yet - “work”? A promising answer on its origin comes from the study conducted by an international team led by Pierangelo Geppetti with the group of researchers of the Pharmacology and Oncology section of the Department of Health Sciences.
The research was published in the scientific journal Nature Communications (“Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice” , DOI: 10.1038/s41467-017-01739-2).
Read more and watch the interview on Medium
